We use analytics to improve your experience. Cookie policy
NYSE · Healthcare · Statistics
Valuation, profitability, balance-sheet health, and risk metrics for LLY — every field resolved through TECHi's unified provider chain (Yahoo → FMP → Finnhub → Alpha Vantage) and labelled with the winning source.
Market cap
$914.52B
Enterprise value
—
P/E (TTM)
53.10
Forward P/E
—
PEG ratio
—
Lower = cheaper for the growth
Price / sales
—
Price / book
—
EPS (TTM)
$18.23
Valuation read
A trailing P/E above 30 means the market is paying up for LLY. That premium has to be earned with above-average revenue or earnings growth — pair this with the forward P/E (—) and the PEG ratio (—) before forming a view.
Gross margin
—
Operating margin
—
Net margin
—
Return on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
>1 = covers near-term liabilities
Beta (5Y)
0.81
Dividend yield
—
No dividend
Shares outstanding
944.82M
52w high
$1133.95
52w low
$623.78
Frequently asked
Eli Lilly and Company (LLY) has a market capitalization of $914.5 billion, computed from the latest share count and the live LLY quote price on TECHi.
Each metric on the LLY Statistics page is resolved through TECHi's unified-fundamentals layer — Yahoo, FMP, Finnhub, Alpha Vantage in priority order — and labelled with the winning provider so you can verify any number.
Live quote-derived stats (52-week range, current ratio, beta) refresh every market session; reported fundamentals (margins, ROE, debt-to-equity) update each time the issuer files a new statement.
